CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.

about

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.

Item

http://www.wikidata.org/entity/Q47171889

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@en

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@nl

type

Item

label

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@en

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@nl

prefLabel

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@en

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@nl

P1476

CMTM5 is downregulated and sup ...... egulating PI3K-AKT signalling.

@en

P2093

Chengxue Dang

http://www.w3.org/2001/XMLSchema#string

Gang Xu

http://www.w3.org/2001/XMLSchema#string

P2860

PI3K and cancer: lessons, challenges and opportunities

Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation.

Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.

Current management of patients with hepatocellular carcinoma.

CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation

Epidemiology of hepatocellular carcinoma: consider the population.

Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.

CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.

Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

P2888

s12935-017-0485-8

P304

113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-017-0485-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1093060035

http://www.w3.org/2001/XMLSchema#string

P698

29213215

http://www.w3.org/2001/XMLSchema#string

P932

5707824

http://www.w3.org/2001/XMLSchema#string